Skip to content

Study · Non-randomized trial · n = 7 · 2005

2 results

Reversibility of androgen deprivation therapy in patients with prostate cancer.

Fridmans A, Chertin B, Koulikov D, Lindenberg T, Gelber H, Leiter C, Farkas A, Spitz IM

The Journal of urology1 Mar 2005Cited by 11 (Europe PMC)

PMID15711270 (opens in a new tab)DOI10.1097/01.ju.0000152330.63175.a5 (opens in a new tab)PepBankPUB-15711270
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In men with prostate cancer, LH remained in the castration range while histrelin hydrogel implants were present.

    In plain wordsIn men with prostate cancer, LH remained in the castration range during histrelin hydrogel implantation.

    Peptide
    Histrelin
    Outcome
    Not applicableLH during implantation
    Study

    n = 7

    Outcome group
    Sex hormones and fertility · Endocrine and hormones
    Studied dose
    Dose not stated · implantAs given in this study (human).

    Source sentences

    Summary
    In group 1 LH and T were in the castration range while implants were in place.
    1 context sentence
    Summary · context
    Group 1 comprised 7 patients treated with histrelin implant, which is inserted into the arm of the patient while under local anesthesia, and suppresses LH and testosterone.
  2. 02HumanNon-randomized trialEfficacy outcome

    In men with prostate cancer, testosterone remained in the castration range while histrelin hydrogel implants were present.

    In plain wordsIn men with prostate cancer, testosterone remained in the castration range during histrelin hydrogel implantation.

    Peptide
    Histrelin
    Outcome
    Not applicableTestosterone during implantation
    Study

    n = 7

    Outcome group
    Sex hormones and fertility · Endocrine and hormones
    Studied dose
    Dose not stated · implantAs given in this study (human).

    Source sentences

    Summary
    In group 1 LH and T were in the castration range while implants were in place.
    1 context sentence
    Summary · context
    Group 1 comprised 7 patients treated with histrelin implant, which is inserted into the arm of the patient while under local anesthesia, and suppresses LH and testosterone.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    28 Oct 2026, 02:03 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:35 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.